Back to top
more

Cardinal Health (CAH)

(Delayed Data from NYSE)

$113.17 USD

113.17
1,065,517

+0.78 (0.69%)

Updated Sep 13, 2024 04:00 PM ET

After-Market: $113.24 +0.07 (0.06%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 36% (160 out of 251)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Top Ranked Income Stocks to Buy for March 19th

by Zacks Equity Research

Here are four stocks with buy rank and strong income characteristics for investors to consider today, March 19th

Is Cardinal Health (CAH) a Solid Pick for Value Investors?

by Zacks Equity Research

Let's see if Cardinal Health (CAH) stock is a good choice for value-oriented investors right now from multiple angles.

CAH vs. ALGN: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

CAH vs. ALGN: Which Stock Is the Better Value Option?

Why Is Cardinal (CAH) Down 12.1% Since Last Earnings Report?

by Zacks Equity Research

Cardinal (CAH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Is Cardinal Health (CAH) Stock Undervalued Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Top Ranked Income Stocks to Buy for March 6th

by Zacks Equity Research

Here are four stocks with buy rank and strong income characteristics for investors to consider today, March 6th

    Here's Why You Should Hold Becton, Dickinson Stock for Now

    by Zacks Equity Research

    Becton, Dickinson's (BDX) MAX enteric viral panel receives FDA clearance.

    Cardinal Health Strong on Pharmaceutical, Competition Rife

    by Zacks Equity Research

    Cardinal Health (CAH) is on track to deliver targeted annualized cost savings of $100 million in fiscal 2019.

    Company News For Feb 8, 2019

    by Zacks Equity Research

    Companies In The News Are: CMG,SPB,HBI,CAH

    Cardinal Health (CAH) Surges: Stock Moves 6.8% Higher

    by Zacks Equity Research

    Cardinal Health (CAH) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.

    Cardinal Health (CAH) Beats on Q2 Earnings, Ups FY19 View

    by Zacks Equity Research

    Cardinal Health's (CAH) Q2 results benefit from strong sales in the Pharmaceutical segment. An upbeat guidance is indicative of brighter prospects.

    Cardinal Health (CAH) Q2 Earnings and Revenues Beat Estimates

    by Zacks Equity Research

    Cardinal (CAH) delivered earnings and revenue surprises of 18.35% and 4.10%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?

    What's in Store for Cardinal Health's (CAH) Q2 Earnings?

    by Zacks Equity Research

    Cardinal Health (CAH) likely to gain from solid Pharmaceutical revenues in fiscal Q2; medical-gloves sub-segment likely to be soft.

    Cardinal Health (CAH) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

    by Zacks Equity Research

    Cardinal (CAH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

    Can Molecular Diagnostics Drive Myriad's (MYGN) Q2 Earnings?

    by Zacks Equity Research

    Myriad (MYGN) likely to deliver solid Q2 results on the diversified Molecular Diagnostics portfolio with products like GeneSight, EndoPredict, BRACAnalysis CDx and Prolaris tests.

    Cigna (CI) Poised to Beat Q4 Earnings on Revenue Growth

    by Zacks Equity Research

    Cigna's (CI) Q4 results are likely to gain from increase in revenues and membership.

    Zacks.com featured expert Kevin Matras highlights: American Airlines, ArcBest, AmerisourceBergen, Cardinal Health and CVS Health

    by Zacks Equity Research

    Zacks.com featured expert Kevin Matras highlights: American Airlines, ArcBest, AmerisourceBergen, Cardinal Health and CVS Health

    5 Stocks in Focus After Recent Broker Rating Upgrades

    by Zacks Equity Research

    The guidance to design a winning portfolio comes from brokers given their thorough understanding of the stock market.

    Zacks.com featured highlights include: ArcBest, American Airlines, Cardinal, Century Aluminum and CVS

    by Zacks Equity Research

    Zacks.com featured highlights include: ArcBest, American Airlines, Cardinal, Century Aluminum and CVS

    5 Broker Favorite Stocks to Watch Out For

    by Zacks Equity Research

    The task of designing one's portfolio to include potential outperformers is not an easy one. Broker advice is necessary to design a winning portfolio.

    Should Value Investors Pick Cardinal Health (CAH) Stock Now?

    by Zacks Equity Research

    Let's see if Cardinal Health, Inc. (CAH) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.

    Cardinal (CAH) Down 4% Since Last Earnings Report: Can It Rebound?

    by Zacks Equity Research

    Cardinal (CAH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

    Is Cardinal Health (CAH) a Great Stock for Value Investors?

    by Zacks Equity Research

    Let's see if Cardinal Health (CAH) stock is a good choice for value-oriented investors right now from multiple angles.

    Cardinal Health to Highlight Cost-Control Approach in ASHP

    by Zacks Equity Research

    Cardinal Health (CAH) helps hospitals identify hidden savings, improve patient outcomes and drive supply chain efficiencies.

    Company News For Nov 8, 2018

    by Zacks Equity Research

    Companies In The News Are: CAH,DHI,TRIP,WYNN